Owner Novartis AG

Inventors Webb, Randy Lee

Agent Davies Collison Cave

Pub. Number AU-A-2011200839

Parent 2006304836

Filing date 25 February 2011

Wipo publication date 17 March 2011

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/365 (2006.01) - Lactones

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/785 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system